Glenn Batchelder
Chairman at Xylocor Therapeutics, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Albert W. Gianchetti | M | 59 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Joanne Martz | F | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 19 years |
Deborah W. Brooks | F | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 24 years |
Todd K. Rosengart | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 11 years |
Shu Kurosaki | M | - |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | - |
Jeff Keefer | M | 71 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 11 years |
Todd Sherer | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 21 years |
Ronald Crystal | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 11 years |
Michael J. Fox | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 24 years |
James L. Wright | M | 76 | 17 years | |
Vincent Cheung | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 7 years |
Mark Levin | M | 73 |
The Possible Project, Inc.
| - |
Holly Barkhymer | F | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 19 years |
Mason Irving | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 17 years |
Jennifer Augusti | F | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Mischa Travers | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 2 years |
Eric Amanfu | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | - |
Nelle Fortenberry | F | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 24 years |
Woody Shackleton | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 17 years |
Ryan Reynolds | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 15 years |
Tracy Pollan | F | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 24 years |
Holly S. Andersen | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 20 years |
Meng Gao | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | - |
Ricky Dean Tigner | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 11 years |
Fenelix Paulino | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | - |
Fred Craves | M | 78 |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | - |
Edward Kalikow | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 13 years |
William R. Geist | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 11 years |
Melanie Bolch Isbill | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 3 years |
Ming Cheah | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 4 years |
Jennifer Lee | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 2 years |
Lizzie Ngo | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Nikhil Thatte | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Carolyn Schenker | F | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 11 years |
Andrew J. O'Brien | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 9 years |
Tony Ho | M | 58 |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 2 years |
David Malek | M | 47 |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | - |
Bonnie Strauss | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 10 years |
George W. Whelen | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 13 years |
Amar Kuchinad | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 12 years |
Carlos Solorzano | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 5 years |
Anne-Cecilie Engell Speyer | F | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 11 years |
Andrew Creighton | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 8 years |
Tony Wyss-Coray | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | - |
Lee Fixel | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 11 years |
Blair Jackson | M | 51 |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | 6 years |
George Robert Stephanopoulos | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 10 years |
Fred G. Weiss | M | 82 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 24 years |
Heather Elizabeth Preston | M | 58 |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 6 years |
Jeffrey Leerink | M | 59 |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | - |
Richard Schnall | M | 54 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 11 years |
David Golub | M | 61 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 24 years |
Ofer Nemirovsky | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 9 years |
Karen Finerman | F | 58 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 19 years |
David Einhorn | M | 55 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 19 years |
Anne Holloway | F | 71 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 6 years |
Karoly Nikolich | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 7 years |
Edwin Arnold Levy | M | 87 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 22 years |
Marc Lipschultz | M | 54 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 15 years |
Robert Tepper | M | 68 |
The Possible Project, Inc.
| 9 years |
Alex Krys | M | 56 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 3 years |
Eldad Melamed | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | - |
Alan Colowick | M | 61 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 6 years |
A. Davis | M | 57 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Fouad Azzam | M | 57 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Donny J. Deutsch | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 22 years |
Mark Booth | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 13 years |
Daniel Hetu | M | - |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Aidan King | M | 53 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | 3 years |
Curtis Schenker | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 24 years |
Frederick Rowe | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 17 years |
John Paul de Koning | M | 55 |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | - |
Peter Zaffino | M | 57 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | - |
Laurence Reid | M | 60 |
The Possible Project, Inc.
| - |
Steve A. Kay | M | - |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | - |
Robert Hopfner | M | 51 |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 7 years |
Barry Cohen | M | 72 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 24 years |
Doug Ostrover | M | 61 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 20 years |
Mark Hart | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 15 years |
Jonathan Michael Brooks | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 17 years |
Ashish Khanna | M | 52 |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 7 years |
Peter Bisgaard | M | 50 |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 7 years |
David Glickman | M | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 11 years |
Jack Quinn | M | 73 |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 3 years |
QIAN WANG | M | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Quisel | M | 52 | 14 years | |
Terry McGuire | M | 68 | 12 years | |
Peter Hutt | M | 89 | 8 years | |
Noubar Afeyan | M | 60 | 7 years | |
Jean George | F | 66 | 15 years | |
Amir Nashat | M | 51 | 8 years | |
Steven D. Ertel | M | 54 | 11 years | |
Jeffrey Hrkach | M | 58 | 7 years | |
Daniel Koerwer | M | 56 | - | |
Christopher Rovaldi | M | 50 | 11 years | |
Carl Gordon | M | 59 | 7 years | |
Lily Safra | F | - |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | 21 years |
Robert J. Steininger | M | 69 | - | |
James V. Desiderio | M | - | 14 years | |
Paul Burgess | M | 50 | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Glenn Batchelder
- Personal Network